PROA_HUCA-HMN

Grupo multidisciplinar convencido del trabajo en EQUIPO
[email protected]

[PROA_HUCA-HMN @HucaProa]

In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA) https://t.co/NNAR5mA1og

[PROA_HUCA-HMN @HucaProa]

Oral Fosfomycin after Carbapenems as De-escalating Therapy in Complicated Urinary Tract Infections: A Randomized Controlled Trial - International Journal of Infectious Diseases https://t.co/qTbJhUtXHy

[PROA_HUCA-HMN @HucaProa]

https://t.co/IcJMz7r9sg

[PROA_HUCA-HMN @HucaProa]

https://t.co/IACqOwfdMG

[PROA_HUCA-HMN @HucaProa]

Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda - eClinicalMedicine https://t.co/H7C7rvAOAD

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥Our article in EJHP is now published🔥🌟s @drgabx @BradSpellberg

“Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?”

We argue that the IDSA AMR guidance recommendation for universal high-dose meropenem (2 g IV q8h as 3h EI) for all infections other than uncomplicated cystitis is largely based on PK/PD extrapolation & expert opinion without supporting clinical outcomes data.
https://t.co/zhFI8w6Bws

[S.Enf.Infecciosas HRUM @infeccHRUmalaga]

A veces #MenosEsMás 📸👇🏻 #desescalar si el microorganismo es:
🔸#sensible
🔸#FocoApropiado para el fármaco
🔸#PK/PD adecuado
👇🏻👇🏻👇🏻
DESESCALA sin miedo❌😨, aunque el paciente “vaya bien” con el atb de amplio espectro.
REVISION desescalada segura🪜⬇️👌 https://t.co/AyNIEzhy8T

[PROA_Macarena - Infecciosas @PROAmacarena]

“PROAfilaxis”

[PROA_HUCA-HMN @HucaProa]

Amoxicillin-Clavulanate vs Amoxicillin for Acute Sinusitis in Adults https://t.co/80uPj9PbI8

[PROA_HUCA-HMN @HucaProa]

Practice variation, outcomes and definitions of suppressive antimicrobial therapy for prosthetic joint infections: a systematic review and expert consensus statement https://t.co/bGQB4Ti2GO

[PROA_HUCA-HMN @HucaProa]

Bacteriuria asintomática en neutropenia febril
https://t.co/0aOp6OUHvr

[PROA_HUCA-HMN @HucaProa]

Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonization treatment in asymptomatic methicillin-resistant Staphylococcus aureus carriers: a longitudinal observational study https://t.co/rZnAnPIBxA

[PROA_HUCA-HMN @HucaProa]

Atención !! Klebsiella pneumoniae liver abscess as the herald of underlying colorectal neoplasm https://t.co/7dAfx7Mp1T

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Missed the biggest ID research of 2025?Here’s your chance to catch up!
🆕🔥Year in Review –Top ID Articles from 2025!
All the most important infectious diseases research in one place!
🤝Huge appreciation to @IDstewardship for helping bring this together!
🔗https://t.co/UCe9OgYpzQ

[PROA_HUCA-HMN @HucaProa]

Antimicrobial resistance in bacterial meningitis caused by Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae (2010–24): a systematic review and meta-analysis - The Lancet Microbe https://t.co/omnaXrNkT5

[PROA_HUCA-HMN @HucaProa]

Antibiotic and Nonantibiotic Drugs Associated With Clostridioides difficile Infection Risk: a Pharmacopoeia-Wide Case-Cohort Study https://t.co/L6bu5vrQKT

[PROA_HUCA-HMN @HucaProa]

Implementation of an early transition to oral antibiotics for patients with non-staphylococcal bacteremia via real-time stewardship intervention https://t.co/yiuu8N3N8f

[PROA_HUCA-HMN @HucaProa]

Candida endocarditis: current perspectives on diagnosis and therapy - Clinical Microbiology and Infection https://t.co/cpHjgWkrIA

[PROA_HUCA-HMN @HucaProa]

Una sola punción para hemocultivos ? https://t.co/acyhe9gP33

[PROA_HUCA-HMN @HucaProa]

Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality https://t.co/dcy22BKM8m